Delivery Order SPE2DB24D2216-SPE2DB25FGNUE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Advair 500-50 Diskus inhalers (60-count units) under a firm fixed-price contract valued at $1,409.40. The order, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,819.65 to AmerisourceBergen Drug Corp for the supply of Advair 500-50 Diskus 60-count inhalers on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a direct procurement of pharmaceutical products to support federal medical supply requirements. The award was issued to AmerisourceBergen's Corporate Office located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,696.20 on May 20, 2025, for the supply of Advair 500-50 Diskus inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,097.68 on April 30, 2025, for the supply of Advair 250-50 Diskus 60 count inhalers, with completion scheduled for May 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Advair 500-50 Diskus inhalers (60-count units) under a firm fixed-price contract valued at $1,376.10. This non-set-aside competitive award represents a child contract issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,911.44 to AmerisourceBergen Drug Corp for Advair 500-50 Diskus 60s pharmaceutical product, with an ultimate completion date of August 18, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $8,311.98 delivery order to AmerisourceBergen Drug Corp for Advair 250-50 Diskus 60-count units, effective April 24, 2025, with final completion scheduled for April 25, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,419.51 to AmerisourceBergen Drug Corp for Advair 500-50 Diskus 60 units, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply requirement fulfilled by the prime contractor from its facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,078.00 to AmerisourceBergen Drug Corp for Advair 250-50 Diskus 60-count inhalers under a firm fixed-price contract type. The award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025, and was not set aside for any socioeconomic category. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,263.51 to AmerisourceBergen Drug Corp for the supply of Advair 250-50 Diskus inhalers (60-count units). This competitively awarded, firm fixed-price delivery order was issued on October 30, 2025, with an ultimate completion date of October 31, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNUEDelivery Order
The Defense Logistics Agency awarded a $5,167.20 delivery order to AmerisourceBergen Drug Corp for Advair 500-50 Diskus inhalers (60-count units) on May 28, 2025, with completion scheduled for May 29, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to fulfill this pharmaceutical supply need through its existing contract vehicle with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal health systems worldwide. The contract reflects the DLA's structured approach to pharmaceutical procurement, ensuring reliable access to essential respiratory medications for the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/28/25 |